Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?

Area of Science:

• Hepatology
• Critical Care Medicine
• Immunology

Background:

• Acute on chronic liver failure (ACLF) is a severe complication of chronic liver disease, characterized by multi-organ failure and high short-term mortality.
• Existing definitions of ACLF and organ failures vary across Europe, North America, and Asia, hindering research progress.
• The pathogenesis involves complex interactions between the immune system, microbiota, and precipitating factors, often complicated by infections.

Purpose of the Study:

• To highlight the need for standardized definitions and a multinational approach to ACLF research.
• To emphasize the multifactorial nature of ACLF pathogenesis and the impact of organ failures.
• To underscore the urgency for novel therapeutic strategies and improved management protocols.

Main Methods:

• Review of current literature on ACLF definitions, pathogenesis, and management strategies.
• Analysis of the impact of extrahepatic organ failures on ACLF prognosis.
• Discussion of emerging therapeutic avenues, including liver transplantation and palliative care.

Main Results:

• ACLF is associated with significant healthcare costs and poor prognosis, particularly in an aging population.
• Infections frequently precipitate or complicate ACLF, exacerbating organ failures.
• Individual organ failures (kidney, brain, lungs, circulation) have cumulative adverse effects on mortality.

Conclusions:

• Standardizing ACLF definitions globally is essential for advancing research and clinical practice.
• Multifactorial pathogenesis necessitates comprehensive strategies targeting immunoinflammation, microbiota, and precipitating factors.
• Novel therapies, liver transplantation, early palliative care, and frailty management are critical for improving ACLF patient outcomes.